Advertisement

Topics

Capillary Biomedical Closes $2.9 Million Series Seed Financing for Commercialization of Novel Insulin Infusion Technology

12:26 EDT 14 Aug 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Funding boosts development of breakthrough infusion set designed to eliminate failures and improve the quality of life for millions of diabetics Capillary Biomedical, Inc. (CapBio) today announced that it has raised $...

Other Sources for this Article

for Capillary Biomedical, Inc.
Paul Williams
310/569-0023
paul@medialinecommunications.com

NEXT ARTICLE

More From BioPortfolio on "Capillary Biomedical Closes $2.9 Million Series Seed Financing for Commercialization of Novel Insulin Infusion Technology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...